Afrocentric Investment (JSE:ACT) ROCE % : 11.99% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Afrocentric Investment ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Afrocentric Investment's annualized ROCE % for the quarter that ended in Dec. 2023 was 11.99%.

Afrocentric Investment ROCE % Historical Data

The historical data trend for Afrocentric Investment's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Afrocentric Investment ROCE % Chart

Afrocentric Investment Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROCE %

Get a 7-Day Free Trial

17.56

18.23

18.51

16.92

11.42

Afrocentric Investment Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															16.37	16.77	12.64	10.37	11.99

Afrocentric Investment ROCE % Calculation

Afrocentric Investment's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	507.627	/	( ( (5437.606 - 995.798)	+	(5559.845 - 1114.364) )	/ 2 )
	=	507.627	/	( (4441.808	+	4445.481)	/ 2 )
	=	507.627	/	4443.6445
	=	11.42 %

Afrocentric Investment's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	540.842	/	( ( (5559.845 - 1114.364)	+	(5560.389 - 980.604) )	/ 2 )
	=	540.842	/	( ( 4445.481	+	4579.785 )	/ 2 )
	=	540.842	/	4512.633
	=	11.99 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Afrocentric Investment (JSE:ACT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Afrocentric Investment ROCE % Related Terms

Thank you for viewing the detailed overview of Afrocentric Investment's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Afrocentric Investment (JSE:ACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Afrocentric Investment Corp Ltd (JSE:ACT) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

37 Conrad Road, Florida North, Roodepoort, ZAF, 1709

Website

http://www.afrocentric.za.com

Afrocentric Investment Corp Ltd is a black-owned investment holding company with an investment portfolio focused on services to the healthcare sector. It seeks to invest in healthcare-related businesses that demonstrate prospects for growth as well as diversify its revenue sources while contributing to the sustainable health and welfare of South African communities. The company provides health administration and health risk management solutions to the healthcare industry. It also provides a range of complementary services to its traditional medical scheme clients and a portfolio of healthcare-related enterprises. These services include information technology solutions, transactional switching, specialized disease management, pharmaceutical wholesaling, amongst others.